Toward an integrative understanding of social phobia

Journal of Psychiatry and Neuroscience

Volumn 26, Issue 3, 2001, Pages 190-202

  Li, D ^a   Chokka, P ^a   Tibbo, P ^a  

^a UNIVERSITY OF ALBERTA HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINOBUTYRIC ACID; DOPAMINE; NORADRENALIN; SEROTONIN;

AMYGDALOID NUCLEUS; ANXIETY NEUROSIS; BRAIN CORTEX; CORPUS STRIATUM; FAMILY STUDY; HUMAN; MOLECULAR GENETICS; NEUROBIOLOGY; NEUROENDOCRINE SYSTEM; NEURORADIOLOGY; NEUROTRANSMISSION; NONHUMAN; PATHOGENESIS; REVIEW; SOCIAL PHOBIA; THALAMUS; TWINS;

ANIMALS; BRAIN; DISEASE MODELS, ANIMAL; GAMMA-AMINOBUTYRIC ACID; GENETIC PREDISPOSITION TO DISEASE; HUMANS; NERVE NET; NEUROTRANSMITTER AGENTS; PHOBIC DISORDERS; TWIN STUDIES;

EID: 0034972967     PISSN: 11804882     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (119)

1. Lifetime and 12-month prevalence of DSM-II-R psychiatric disorders in the United States
2. Social phobia in general health care: An unrecognised undertreated disabling disorder
3. Form and frequency of mental disorders across centres
4. Identification of cases of anxiety disorders and affective disorders in the community according to ICD-10 and DSM-III-R by using the Composite International Diagnostic Interview (CID)
5. Age at onset of selected mental disorders in five community populations
6. Social phobia: Comorbidity and morbidity in an epidemiologic sample
7. The epidemiology of social phobia: Findings from the Duke Epidemiological Catchment Area Study
8. A direct interview family study of social phobia
9. A high-risk pilot study of the children of adults with social phobia
10. Generalized social phobia: Reliability and validity
11. A direct-interview family study of generalized social phobia
12. The genetic epidemiology of phobias in women: The interrelationship of agoraphobia, social phobia, situation phobia and simple phobia
13. Fears and phobias: Reliability and heritability
14. Temperament and the reactions to unfamiliarity
15. Behavioral inhibition in childhood: A risk factor for anxiety disorders
16. Temperament, emotion, and cognition at fourteen months: The MacArthur Longitudinal Twin Study
17. 2 receptor (DRD2), and dopamine transporter (DAT1) genes with schizoid/avoidant behaviors (SAB)
18. Dopamine reuptake site densities in patients with social phobia
19. 2 receptor binding potential in social phobia
20. 4 dopamine receptor gene and measures of novelty seeking
21. 4 receptor exon III polymorphism associated with the human personality trait of novelty seeking
22. 4 receptor (D4DR) exon III repeat polymorphism and the human personality trait of novelty seeking
23. 4 receptor (DRD4) exon III polymorphism and measures of novelty seeking in a German population
24. 4 receptor gene polymorphisms
25. No association between novelty seeking and the type 4 dopamine receptor gene (DRD4) in two New Zealand samples
26. 4 receptor gene and personality traits
27. 4 receptor (D4DR) 16 amino acid repeat polymorphism and novelty seeking
28. 4 receptor (D4DR) exon III seven repeat alleles in Baltimore Longitudinal Study of Aging participants
29. Levels of urinary free cortisol in social phobia
30. Normal urinary free cortisol and post dexamethasone cortisol in social phobia
31. Salivary cortisol levels in socially phobic adolescent girls
32. The hypothalamic-pituitary-thyroid axis in social phobia
33. Effects of thyrotropin releasing hormone on blood pressure and heart rate in social phobia patients, panic disorder patients, and normal controls: Results of a pilot study
34. Heart rate and plasma norepinephrine responsivity to orthostatic challenge in anxiety disorders
35. Autonomic responsivity in generalized social phobia
36. Abnormal cardiovascular responses to standing in panic disorder and social phobia
37. Responses of "generalized" and "discrete" social phobics during public speaking
38. DSM-III-R subtypes of social phobia: Comparison of generalized phobics and public speaking phobics
39. Psychophysiological differences between subgroups of social phobia
40. Anxiety and growth disturbance: Is there a connection? A review of biological studies in social phobia
41. Neuroendocrine, physiologic, and behavioral responses to clonidine in patients with social phobia
42. Neurobiology of social phobia
43. The neurobiology of social phobia
44. Lymphocyte β-adrenoceptors in social phobia
45. Plasma neuropeptide Y in anxiety disorders: Findings in panic disorder and social phobia
46. Neuropeptide Y-related peptides and their receptors - Are the receptors potential therapeutic drug targets?
47. Neuropeptide Y and sympathetic neurotransmission
48. Phenelzine versus atenolol in social phobia. A placebo-controlled comparison
49. Social phobia: A comparison of behavior therapy and atenolol
50. The treatment of social phobia: Real-life rehearsal with non-professional therapists
51. Beneficial effect of nadolol on anxiety-reduced disturbances of performance in musicians: A comparison with diazepam and placebo
52. Effect of oxprenolol on stage-fright in musicians
53. Specificity of lactate infusions in social phobia versus panic disorder
54. Epinephrine infusions in patients with social phobia
55. Ventilatory physiology of patients with panic disorder
56. Lactate response to caffeine in panic disorder: A replication using an "anxious" control group
57. Serotonin receptor 1A knockout: An animal model of anxiety-related disorder
58. 1C receptor antagonists have anxiolytic-like actions in the rat social interaction model
59. 3 receptor antagonists in the social interaction and elevated plus-maze tests of anxiety in the rat
60. Anxiolytic-like effect of paroxetine in a rat social interaction test
61. Neurobiological perspectives on social phobia: From affiliation to zoology
62. Serotonergic mechanisms promote dominance acquisition in adult male vervet monkeys
63. Selective alteration of personality and social behavior by serotonergic intervention
64. Sertraline for social phobia: A double-blind, placebo-controlled crossover study
65. Recent advances in the psychopharmacology of social phobia
66. Paroxetine treatment of generalized social phobia (social anxiety disorder): A randomized controlled trial
67. Paroxetine in social phobia/social anxiety disorder: Randomised, double-blind placebo-controlled study
68. Modifications of the serotonin system by antidepressant treatments: Implications for the therapeutic response in major depression
69. Pharmacotherapy of social phobia: A controlled study with moclobemide and phenelzine
70. Neurobiology of social phobia
71. Serotonergic function in social phobia: Comparison to normal control and obsessive-compulsive disorder subjects
72. Obsessive-compulsive disorder in schizophrenia: Epidemiologic and biologic overlap
73. A neurobiological basis of social attachment
74. Serotonin axon terminals in the ventral tegmental area of the rat: Fine structure and synaptic input to dopaminergic neurons
75. Effects of sertraline and citalopram given repeatedly on the responsiveness of 5-HT receptor subpopulations
76. Differential effects of acute and chronic fluoxetine administration on the spontaneous activity of dopaminergic neurones in the ventral tegmental area
77. Chronic fluoxetine treatment up-regulates dopamine receptors in the mesolimbic forebrain of the rat
78. The epidemiology of social phobia: Findings from the Duke Epidemiological Catchment Area Study
79. Magnetic resonance spectroscopy in social phobia: Preliminary findings
80. Cognitive-behavioral and pharmacological treatments of social phobia: A controlled study
81. Clonazepam in the treatment of social phobia: A pilot study
82. Treatment of social phobia with gabapentin: A placebo-controlled study
83. Abnormal peripheral benzodiazepine receptor density associated with generalized social phobia
84. Flumazenil challenge in social phobia
85. Benzodiazepine receptor imaging in the brain: Recent developments and clinical validity
86. MAOIs: Impact on social behavior
87. CSF dopamine levels correlate with extraversion in depressed patients
88. Plasma and CSF HVA levels in panic patients with comorbid social phobia
89. Phenelzine versus imipramine in atypical depression: A preliminary report
90. Genetic differences in social behavior: Neurobiological mechanisms in a mouse model
91. School avoidance and social phobia triggered by haloperidol in patients with Tourette's syndrome
92. Magnetic resonance imaging in social phobia
93. Anxiety disorders in familial Parkinsonism
94. Anxiety disorders in patients with Parkinson's disease
95. Neostriatal mechanisms in Parkinson's disease
96. 2 receptor binding characteristics in cynomolgus monkeys assessed with positron emission tomography
97. 2 receptor gene and their relationships to striatal dopamine receptor density of healthy volunteers
98. 2 dopamine receptors and personality traits
99. 2 receptor density and personal detachment in healthy subjects
100. Prediction of detached personality in healthy subjects by low dopamine transporter binding
101. The prevalence of comorbid anxiety in schizophrenia, schizoaffective disorder and bipolar disorder
102. A repeat proton magnetic resonance spectroscopy study in social phobia
103. Treatment of social phobia with clonazepam and placebo
104. Muscarinic receptor activation of phosphatidylcholine hydrolysis: Relationship to phosphoinositide hydrolysis and diacylglycerol metabolism
105. 1H spectroscopy. Glutamate and glutamine, myo-iositol and related metabolites
106. A neuroanatomical hypothesis for panic disorder
107. A brain single photon-emission computed tomography (SPECT) study of generalized social phobia
108. The neurobiology of social phobia
109. PET studies in experimental and pathological anxiety
110. Brain mechanisms of social anxiety disorder
111. The functional anatomy, neurochemistry, and pharmacology of anxiety
112. The noradrenergic system in pathological anxiety: A focus on panic with relevance to generalized anxiety and phobias
113. The concepts of the ventral striatopallidal system and extended amygdala
114. Functional and anatomical relationships among the amygdala, basal forebrain, ventral striatum, and cortex: An integrative discussion
115. Emotion: Clues from the brain
116. Subcortical correlates of differential classical conditioning of aversive emotional reactions in social phobia